Tag: Abbott
Sequel Med Tech collaborates with Abbott
March 19, 2025HME News Staff
MANCHESTER, N.H. – Sequel Med Tech has announced that Abbott’s FreeStyle Libre 3 Plus sensor will be the first continuous glucose monitoring device to work with its twiist Automated Insulin Delivery (AID) System powered by Tidepool. The sensor will be compatible with twiist when the system is expected to launch in the second quarter of 2025. “We are thrilled to announce our collaboration with Abbott, integrating its world-leading FreeStyle Libre technology as our first CGM partner,...
In brief: Trump turnaround, Homecare Champion finalists, TrueAire recall
February 7, 2025HME News Staff
WASHINGTON - President Donald Trump on Feb. 3 suspended his plans to implement 25% tariffs on products from Mexico and Canada, agreeing to a one-month pause in exchange for concessions on border security and crime enforcement.
The DME industry is closely monitoring the situation to see what, if any, exclusions might be included for medical equipment and products, according to a bulletin from VGM Government Relations.
An increase in tariffs, VGM says, could lead to several...
Abbott launches initiative to battle diabetes misconceptions
February 6, 2025HME News Staff
ABBOTT PARK, Ill. – Abbott has launched Above the Bias, a global initiative to drive awareness about the health impact that common misconceptions and bias about diabetes can have on people living with the condition.
The initiative includes results from a new survey and a film that highlights how everyday comments impact people with diabetes.
"How many times have we heard ‘That looks like diabetes on a plate’ when we’re watching a movie, eating at a restaurant...
In brief: Medline’s IPO, GLP-1's expansion, DME’s ‘hidden cost,’ Nymbl’s investment
January 3, 2025HME News Staff
NORTHFIELD, Ill. – Medline has confidentially submitted a draft registration statement on Form S-1 to the U.S. Securities and Exchange Commission for a proposed initial public offering of its common stock.
The number of shares to be offered and the price range for the proposed offering have not yet been determined. The offering is subject to market and other conditions and the completion of the SEC's review process.
In 2021, Medline announced it had received outside...
Abbott, DexCom settle patent disputes
January 2, 2025HME News Staff
SAN DIEGO and ABBOTT PARK, Ill. – DexCom and Abbott Diabetes Care have entered into a settlement and patent cross license agreement to resolve all outstanding patent litigation between the parties related to their continuous glucose monitors, according to a Form 8-K filed by Dexcom with the U.S. Securities and Exchange Commission. Both companies have accused the other of infringing certain patents and each company has filed counterclaims and actions to invalidate the other’s patents....
Abbott opens new facility for sensors, CGMs
November 18, 2024HME News Staff
ABBOTT PARK, Ill. – Abbott on Nov. 18 held a ceremony to celebrate the official opening of a state-of-the-art manufacturing facility in Kilkenny, Ireland, part of its €440 million investment in the country. The new 30,000-square-meter Kilkenny facility is producing FreeStyle Libre 3 sensors and the latest generation in Abbott’s continuous glucose monitoring portfolio for people living with diabetes. "This is our latest commitment to providing innovative care and supporting...
FDA says OK to leave FreeStyle Libre CGMs on for imaging
October 30, 2024HME News Staff
ABBOTT PARK, Ill. – Users of the FreeStyle Libre 2 and 3 continuous glucose monitoring systems from Abbott no longer need to remove and discard the devices for imaging procedures, such as X-rays, CT scans and MRIs. The U.S. Food and Drug Administration has cleared the removal of the imaging contraindication, making Abbott’s systems the first and only patient-applied CGM sensors approved for these screenings. "For people with diabetes, especially those using insulin, removing a CGM...
In brief: Apple Watch, SOAR Act, Abbott Lingo, MAC consolidation
September 11, 2024HME News Staff
CUPERTINO, Calif. – Apple on Sept. 9 unveiled Apple Watch Series 10, which among other things, features a new sleep apnea feature.
Building on the intelligent health features already available to track key overnight metrics such as heart rate, respiratory rate and wrist temperature, the watch’s new sleep apnea feature can help identify signs of sleep apnea, the company says, by using the accelerometer to monitor small movements at the wrist that are associated with interruptions...
Abbott recalls certain sensors
September 9, 2024HME News Staff
ABBOTT PARK, Ill. - Abbott has issued a recall for certain FreeStyle Libre 3 sensors due to a risk for inaccurate high glucose readings. On July 24, the company sent all affected customers an urgent medical device recall recommending they, among other things, immediately discontinue use and dispose of any affected sensors, and request a replacement for any affected seniors. Abbott initiated the recall after finding that a small number of FreeStyle Libre 3 sensors may provide incorrect high glucose...
Abbott launches consumer biowearable
September 9, 2024HME News Staff
ABBOTT PARK, Ill. - Abbott has announced the U.S. availability of Lingo, the company’s first glucose monitoring system available without prescription.
The Lingo system includes a biosensor and a mobile app designed for consumers who want to improve their overall health and wellness, the company says.
"There is a great deal of interest in tracking biomarkers that provide insights into one's health and wellness that were previously undetectable using the trackers available...